As low HRP2 expression is associated with poor outcomes in patients with MM, we evaluated HRP2 expression in 2 of our previously established bortezomib-resistant MM cell lines derived from MM.1S and LP-1 cells (28). This evidence concerns the gene HDGFL2 and Miyoshi myopathy.